How to Prepare for a Successful Career in Video Production

This is In Focus, by MarketScale. A podcast by video professionals for video professionals, putting in focus the topics, teachers and tips guiding the video industry today. With your host, MarketScale’s Sr. Director of Video Production, Josh Brummett.

 

The job market is constantly changing, and the job qualifications that would have been sufficient five or 10 years ago may not necessarily be sufficient today. Many professionals still debate whether or not a degree in video production is necessary to get started in the industry.

But is this true today? What does someone need to get their foot in the door with the company of their dreams?

In this episode of In Focus, Josh Brummet meets with two of MarketScale’s most recent hires in the video production department, Michael Boyer and Alex LeBlanc, to discuss how to get started in video production today.

Michael Boyer is MarketScale’s live broadcast creative producer, with a degree in Convergence Journalism from The University of Missouri. Meanwhile, video production specialist Alex LeBlanc has a degree in Advertising and another in Electronic Media & Communication, both from Texas Tech University.

Both of them believed that, while going to school for video production isn’t obligatory, educational institutions offer certain benefits that a do-it-yourself producer wouldn’t have. “What you don’t get outside of school is the connections you build while attending university,” said LeBlanc.

“Every group is kind of a group project, and you can’t do anything by yourself,” added Boyer. “Learning from people that were better than me helped me to become better too.”

But for those who don’t plan on attending college, what’s the best way to learn?

“You learn by doing things,” said Boyer. By replicating what other people are doing and pushing ideas to their fullest, anyone can get better at their craft. “Even if you fall terribly short, you’ll still learn something valuable.”

Follow In Focus Every Other Friday!

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More